From - A Hematology Oncology Wiki
Jump to navigation Jump to search

The purpose of this page is to record, in reverse chronological order, conversations about content changes for the accompanying main page.

April 2018

  • User:Seemanagpal: some of the studies listed are actually in sub-set populations; specifically Malmstrom and now Perry are "elderly" or "poor performance" GB and should be labelled as such because that isnt what we should be doing in good risk patients. Additionally, the MGMT breakdown in the Malmstrom trial allows for some commentary on if you have an MGMT + elderly patient v MGMT negative
    • User:Jwarner: a new section of adjuvant therapy for elderly and poor performance status patients has been added